Home
Christopher Ryan Sullivan, CFO: Avalo Therapeutics AVTX Sell · Filed 05/01
Trade details
- Type
- Insider sale
- Amount
- $111,886.11
- Shares · price
- 8,457 sh · $13.23 a share
- Held after
- 423 sh
- Trade date
- 26/04/30
- Filed
- 26/05/01
- Days to filing
- 1 days
Sold 95.2% of holdings
- Share of holding sold
- 95.2%
Avalo Therapeutics trades, last 26 weeks
What else happened in Avalo Therapeutics around then
Filed or reported within 30 days of the trade day · 03/31~05/30Christopher Ryan Sullivan's recent trades
- Christopher Ryan Sullivan
Planned saleAvalo Therapeutics
Planned saleAvalo Therapeutics
AVTX
$622.2K
31,031 sh
$622.2K
Filed 08/18
Traded 08/18
- Christopher Ryan Sullivan
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 planAvalo Therapeutics
AVTX
$1.4M
70,709 sh
$1.4M
Filed 08/17
Traded 08/17
- Christopher Ryan Sullivan
Planned saleAvalo Therapeutics
Planned saleAvalo Therapeutics
AVTX
$74.8K
3,749 sh
$74.8K
Filed 08/17
Traded 08/17
- Christopher Ryan Sullivan
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 planAvalo Therapeutics
AVTX
$448.8K
18,606 sh
$448.8K
Filed 05/11
Traded 05/07
- Christopher Ryan Sullivan
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 planAvalo Therapeutics
AVTX
$405.8K
18,606 sh
$405.8K
Filed 05/07
Traded 05/07